BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26087423)

  • 1. Beta-blockers for childhood vascular tumors.
    Bayart CB; Brandling-Bennett HA
    Curr Opin Pediatr; 2015 Aug; 27(4):454-9. PubMed ID: 26087423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of topical beta blockers as treatment for infantile hemangiomas.
    Painter SL; Hildebrand GD
    Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists.
    Wine Lee L; Goff KL; Lam JM; Low DW; Yan AC; Castelo-Soccio L
    Pediatr Dermatol; 2014; 31(2):203-7. PubMed ID: 24138457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on infantile hemangiomas.
    Lee KC; Bercovitch L
    Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
    Marey HM; Elmazar HF; Mandour SS; Khairy HA
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N; Guo S; Langer P
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-blockers in the treatment of periocular infantile hemangioma.
    Al-Haddad C; El Salloukh NA; El Moussawi Z
    Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical timolol for small hemangiomas of infancy.
    Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
    Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
    Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-blocker therapy for infantile hemangioma.
    Koh SP; Leadbitter P; Smithers F; Tan ST
    Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
    Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
    Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.